LobbyingChristopher and Dana Reeve Foundation lobbying by quarter
Christopher and Dana Reeve Foundation's latest lobbying report covers Q2 2026, at $5,000. The four quarters Q3 2025–Q2 2026 total $20K. Its first report covers Q4 2022; the issues it reports most are Budget/Appropriations and Health Issues.
Christopher and Dana Reeve Foundation
- Latest quarter
- $5,000
- Q2 2026 · 1 reports
- Last 12 months
- $20K
- Last 4 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q4 2022
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q4 2022 | $5,000 | 1 |
| Q1 2023 | $5,000 | 1 |
| Q2 2023 | $5,000 | 1 |
| Q3 2023 | $5,000 | 1 |
| Q4 2023 | $5,000 | 1 |
| Q1 2024 | $5,000 | 1 |
| Q2 2024 | $5,000 | 1 |
| Q3 2024 | $5,000 | 1 |
| Q4 2024 | $5,000 | 1 |
| Q1 2025 | $5,000 | 1 |
| Q2 2025 | $5,000 | 1 |
| Q3 2025 | $5,000 | 1 |
| Q4 2025 | $5,000 | 1 |
| Q1 2026 | $5,000 | 1 |
| Q2 2026 | $5,000 | 1 |
Policy issues the reports name
- Budget and appropriations15 reports
- Health issues15 reports
- Medicare and Medicaid15 reports
A report that names several issues counts once for each.
Who was lobbied
- HOUSE OF REPRESENTATIVES15 reports
- SENATE15 reports
Firms it paid
| Firm | ||
|---|---|---|
| Waxman Strategies | $75K | 15 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| JEREMY SHARP | LA,Rep Capps 2001-05 PSM, Sen HELP Comm 2007-10 LD, Sen Dodd 2010 DAS for Leg, HHS, 2011-13 Counselor, HHS, 2013-14 Dep Commissioner for Policy, FDA 2015-17 | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/14for Q2 | Waxman Strategies | $5,000 |
| 04/20for Q1 | Waxman Strategies | $5,000 |
| 01/13for Q4 2025 | Waxman Strategies | $5,000 |
| 25/10/14for Q3 2025 | Waxman Strategies | $5,000 |
| 25/07/15for Q2 2025 | Waxman Strategies | $5,000 |
| 25/04/25for Q1 2025 | Waxman Strategies | $5,000 |
| 25/01/14for Q4 2024 | Waxman Strategies | $5,000 |
| 24/10/17for Q3 2024 | Waxman Strategies | $5,000 |
| 24/07/15for Q2 2024 | Waxman Strategies | $5,000 |
| 24/04/16for Q1 2024 | Waxman Strategies | $5,000 |
| 24/01/18for Q4 2023 | Waxman Strategies | $5,000 |
| 23/11/06for Q3 2023 | Waxman Strategies | $5,000 |
| 23/07/17for Q2 2023 | Waxman Strategies | $5,000 |
| 23/04/20for Q1 2023 | Waxman Strategies | $5,000 |
| 23/01/17for Q4 2022 | Waxman Strategies | $5,000 |